Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × Dexamethasone × Clear all

NCT03107182 2025-05-06

OPTIMA-II

Phase 2 Completed

72 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck

NCT06102447 2023-10-26

Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck

NCT01748942 2018-06-19

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

Phase NA Completed

76 enrolled 20 charts

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Pain

NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Phase 2 Terminated

6 enrolled 5 charts

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

NCT02061631 2015-10-08

DECIDE

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00507858 2011-09-23

Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell